Precision Oncology Trends and Forecast
The future of the global precision oncology market looks promising with opportunities in the hospitals & diagnostic laboratory, pharmaceutical & biotechnology company, and healthcare data company markets. The global precision oncology market is expected to reach an estimated $182.8 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are technological advancements, increasing demand for diagnostic products to have effective results with minimal side effects in cancer patients, and addressing specific drug resistance issues.A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Precision Oncology by Segment
The study includes a forecast for the global precision oncology by product type, cancer type, end use, and region.Precision Oncology Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Diagnostics
- Therapeutics
Precision Oncology Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
- Breast Cancer
- Cervical Cancer
- Prostate Cancer
- Lung Cancer
- Others
Precision Oncology Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Healthcare Data Companies
Precision Oncology Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Precision Oncology Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision oncology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision oncology companies profiled in this report include-- Thermo Fisher Scientific
- Invitae
- Qiagen
- Illumina
- Laboratory Corporation
- Exact Sciences
- Rain Oncology
- Strata Oncology
- Xilis
- Variantyx
Precision Oncology Market Insights
The publisher forecasts that diagnostics is expected to witness highest growth over the forecast period due to rising demand of early intervention and treatment for cancer, improved diagnostic imaging and testing techniques, and demand of personalised medicines based on daignosis results.Within this market, hospitals & diagnostic laboratories will remain the largest segment due to global expansion of diagnostics facilities is predicted to accelerate segment growth.
APAC is expected to witness highest growth over the forecast period due to surge in aging population, rising investment in the healthcare infrastructure, and growing demand of personalized medicine in the region.
Features of the Global Precision Oncology Market
- Market Size Estimates: Precision oncology market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Precision oncology market size by product type, cancer type, end use, and region in terms of value ($B).
- Regional Analysis: Precision oncology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, end uses, and regions for the precision oncology market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision oncology market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the precision oncology market size?Answer: The global precision oncology market is expected to reach an estimated $182.8 billion by 2030.
Q.2 What is the growth forecast for precision oncology market?
Answer: The global precision oncology market is expected to grow with a CAGR of 9.0% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the precision oncology market?
Answer: The major drivers for this market are technological advancements, increasing demand for diagnostic products to have effective results with minimal side effects in cancer patients and addressing specific drug resistance issues.
Q4. What are the major segments for precision oncology market?
Answer: The future of the precision oncology market looks promising with opportunities in the hospitals & diagnostic laboratory, pharmaceutical & biotechnology company, and healthcare data company markets.
Q5. Who are the key precision oncology market companies?
Answer: Some of the key precision oncology companies are as follows:
- Thermo Fisher Scientific
- Invitae
- Qiagen
- Illumina
- Laboratory Corporation
- Exact Sciences
- Rain Oncology
- Strata Oncology
- Xilis
- Variantyx
Answer: The publisher forecasts that diagnostics is expected to witness highest growth over the forecast period due to rising demand of early intervention and treatment for cancer, improved diagnostic imaging and testing techniques, and demand of personalised medicines based on daignosis results.
Q7. In precision oncology market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to surge in aging population, rising investment in the healthcare infrastructure, and growing demand of personalized medicine in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the precision oncology market by product type (diagnostics and therapeutics), cancer type (breast cancer, cervical cancer, prostate cancer, lung cancer, and others), end use (hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and healthcare data companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Precision Oncology Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific
- Invitae
- Qiagen
- Illumina
- Laboratory Corporation
- Exact Sciences
- Rain Oncology
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
